Effects of vasodilators on the signal intensity of perfluorocarbon monitored by in vivo 19F-NMR spectroscopy

Magnetic Resonance Imaging

Volumn 15, Issue 3, 1997, Pages 341-345

  Sogabe, Takayuki ^a   Imaizumi, Takashi ^a   Mori, Toyoki ^a   Tominaga, Michiaki ^a   Koga, Keiko ^a   Yabuuchi, Youichi ^a  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

19F NMR; Perfluorocarbon; Rat gastrocnemius; Vasodilators

Indexed keywords

FLUOROCARBON; GLYCERYL TRINITRATE; HYDRALAZINE;

ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; GASTROCNEMIUS MUSCLE; HEMODYNAMICS; IMAGE RECONSTRUCTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RAT; VASODILATATION;

ANIMALS; ARTERIOLES; BLOOD PRESSURE; BLOOD VESSELS; BLOOD VOLUME; FLUORINE; FLUOROCARBONS; HEART RATE; HINDLIMB; HYDRALAZINE; IMAGE ENHANCEMENT; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MUSCLE, SKELETAL; MUSCLE, SMOOTH, VASCULAR; NITROGLYCERIN; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; SODIUM CHLORIDE; VASODILATOR AGENTS; VEINS;

ANIMALIA;

EID: 0030969831     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(96)00382-7     Document Type: Article

References (18)

1. 1. Shepherd, J.T.; Vanhoutte, P.M. Role of the venous system in circulatory control. Mayo Clin. Proc. 53:247-255; 1978.
2. 2. Mirkin, B.L.; Sinaiko, A.R. Vasodilators. In: G. Onesti; K.E. Kim (Eds). Hypertension in the Young and the Old. New York: Grune and Stratton; 1981: pp. 221-227.
3. 3. Schwartz, A.B.; Chatterjee, K. Vasodilator therapy in chronic congestive heart failure. Drugs 26:148-173; 1983.
4. 4. Tabrizchi, R.; Pang, C.C.Y. Effects of drugs on body venous tone, as reflected by mean circulatory filling pressure. Cardiovasc. Res. 26:443-448; 1992.
5. 5. Colardyn, F.; Clement, D.L. Differential effects of vasodilators on forearm and calf vessels. Angiology 41:313-317; 1990.
6. 6. Taira, N.; Imai, Y.; Hiwatari, M. Differential effects of nitroglycerin, trimetazidine, verapamil and SK&F 24260 on venous return by the open-loop method in the dog. Jpn. J. Pharmacol. 30:449-461; 1980.
7. 19F NMR. J. Pharm. Pharmacol. 36:556-559; 1984.
8. 8. Thomas, C.; Counsell, C.; Sansom, J.; Wood, P.; Stratford, I.; Adams, G. The perfluorocarbon emulsion PFOB: potential indicator of change in blood volume using fluorine-19 NMR spectroscopy. EXS 61:362-367; 1992.
9. 19F-magnetic resonance determination of myocardial blood volume. Magn. Reson. Med. 34:628-631; 1995.
10. 125I]-albumin and correlation to tumor size. Magn. Reson. Imaging 14:275-280; 1996.
11. 19F NMR. Magn. Reson. Med. 8:80-83; 1988.
12. 19F-NMR spectroscopy. Int. J. Radiat. Biol. 60:219-223; 1991.
13. 13. Haywood, J.R.; Shaffer, R.A.; Fastenow, C.; Fink, G.D.; Brody, M.J. Regional blood flow measurement with pulsed doppler flowmeter in Conscious Rat. Am. J. Physiol. 241:H273-H278; 1981.
14. 14. Hashim, M.A.; Tadepalli, A.S. Hemodynamic responses evoked by endothelin from central cardiovascular neural substrates. Am. J. Physiol. 262:H1-H9; 1992.
15. 19F NMR probes of oxygen tension and temperature. J. Magn. Reson. Series B 106: 131-141; 1995.
16. 19F Magnetic resonance imaging of the reticuloendothelial system. Magn. Reson. Med. 5:548-554; 1987.
17. 17. Parratt, J.R. Nitroglycerin - The first one hundred years: New facts about an old drug. J. Pharm. Pharmacol. 31:801-809; 1979.
18. 18. Koch-Weser, J. Hydralazine. N. Engl. J. Med. 295: 320-323; 1976.